CID 16204741

(4r,7s,10s,13s,16r,17e,19r,22s,25s,28s,31r)-31-[[(2r)-3-(1-adamantylmethylsulfanyl)-2-[[(2s)-2-[[(2s)-2-amino-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-19,22-bis(4-aminobutyl)-n-[(2s)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]-10,25-bis(3-carbamimidamidopropyl)-7-[3-(carbamoylamino)propyl]-13,28-bis[(4-hydroxyphenyl)methyl]-16-methyl-6,9,12,15,21,24,27,30-octaoxo-1,2-dithia-5,8,11,14,20,23,26,29-octazacyclodotriacont-17-ene-4-carboxamide

Structural Information

Molecular Formula
C90H151N33O16S3
SMILES
C[C@@H]1/C=C/[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC2=CC=C(C=C2)O)CCCNC(=N)N)CCCNC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N)NC(=O)[C@H](CSCC34CC5CC(C3)CC(C5)C4)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)N)CC6=CC=C(C=C6)O)CCCNC(=N)N)CCCCN)CCCCN
InChI
InChI=1S/C90H151N33O16S3/c1-50-20-25-56(12-2-4-30-91)112-74(129)61(14-3-5-31-92)115-75(130)63(17-9-35-109-87(101)102)118-80(135)67(42-52-23-28-58(125)29-24-52)120-83(138)70(123-81(136)68(46-140-49-90-43-53-38-54(44-90)40-55(39-53)45-90)121-77(132)62(16-8-34-108-86(99)100)114-73(128)59(93)13-6-32-106-84(95)96)48-142-141-47-69(82(137)113-60(71(94)126)15-7-33-107-85(97)98)122-78(133)65(19-11-37-111-89(105)139)116-76(131)64(18-10-36-110-88(103)104)117-79(134)66(119-72(50)127)41-51-21-26-57(124)27-22-51/h20-29,50,53-56,59-70,124-125H,2-19,30-49,91-93H2,1H3,(H2,94,126)(H,112,129)(H,113,137)(H,114,128)(H,115,130)(H,116,131)(H,117,134)(H,118,135)(H,119,127)(H,120,138)(H,121,132)(H,122,133)(H,123,136)(H4,95,96,106)(H4,97,98,107)(H4,99,100,108)(H4,101,102,109)(H4,103,104,110)(H3,105,111,139)/b25-20+/t50-,53?,54?,55?,56-,59+,60+,61+,62+,63+,64+,65+,66+,67+,68+,69+,70+,90?/m1/s1
InChIKey
XTEHZFQHFIXTPO-FTPLASCUSA-N
Compound name
(4R,7S,10S,13S,16R,17E,19R,22S,25S,28S,31R)-31-[[(2R)-3-(1-adamantylmethylsulfanyl)-2-[[(2S)-2-[[(2S)-2-amino-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-19,22-bis(4-aminobutyl)-N-[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]-10,25-bis(3-carbamimidamidopropyl)-7-[3-(carbamoylamino)propyl]-13,28-bis[(4-hydroxyphenyl)methyl]-16-methyl-6,9,12,15,21,24,27,30-octaoxo-1,2-dithia-5,8,11,14,20,23,26,29-octazacyclodotriacont-17-ene-4-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

2046.1179 Da
Monoisotopic Mass

-3.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2047.1252 211.4
[M+Na]+ 2069.1071 204.0
[M-H]- 2045.1106 209.5
[M+NH4]+ 2064.1517 206.7
[M+K]+ 2085.0811 206.0
[M+H-H2O]+ 2029.1152 190.2
[M+HCOO]- 2091.1161 206.8
[M+CH3COO]- 2105.1318 209.0
[M+Na-2H]- 2067.0926 253.9
[M]+ 2046.1174 188.3
[M]- 2046.1184 188.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.